1,000+ Cured! THIRD French Study Affirms HCQ is COVID19 ‘Game Changer’

Written by John O'Sullivan

The third clinical study for hydroxychloroquine (HCQ) as treatment for COVID19 by world-renowned infectious diseases specialist, Professor Didier Raoult again proves to be astonishingly successful. The ‘Trump Cure‘ had a success rate of 93{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117} after only three days on the drugs.

Professor Raoult affirms that HCQ treatment in his clinical trials performed at IHU Méditerranée Infection, Marseille, France with a cohort of 1061 continues to provide an almost perfect rate of success.

Widely touted as the ‘Trump Cure’ in light of the US President’s strident claims the drug was a ‘gamechanger’ (March 21, 2020) a growing number of independent trials have been undertaken.

Despite huge criticism from the mainstream media for going against the advice of experts, it appears the empirical evidence once again comes down firmly on the side of Donald Trump.

For this third trial Raoult’s French patients were treated for at least 3 days with the HCQ-AZ combination and a follow-up of at least 9 days was investigated.

The full PDF of the findings are found here. [1]

To date Professor Raoult’s team has the following success rate over three such trials as follows:

March 17, 2020 : ‘Trump Cure’, First Paper published, N-count 20 – 100{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117} cured totally, 6 days of pills

: ‘Trump Cure’, First Paper published, N-count 20 – 100{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117} cured totally, 6 days of pills March 27, 2020 : ‘Trump Cure’, Second Paper published, N-count 80 – 99{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117} of dying cured totally, 8 days of pills

: ‘Trump Cure’, Second Paper published, N-count 80 – 99{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117} of dying cured totally, 8 days of pills April 9, 2020 : ‘Trump Cure’, Third Paper abstract, N-count 1,061 – 91.7{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117}{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117} of semi-sick cured, 3 days of pills (only 3!)

Below are excepts from the professor’s paper:

ABSTRACT

Background

In a recent survey, most physicians worldwide considered that hydroxychloroquine (HCQ)

and azithromycin (AZ) are the two most effective drugs among available molecules against

COVID-19. Nevertheless, to date, one preliminary clinical trial only has demonstrated its

efficacy on the viral load. Additionally, a clinical study including 80 patients was published,

and in vitro efficiency of this association was demonstrated.

Methods

The study was performed at IHU Méditerranée Infection, Marseille, France. A cohort of 1061

COVID-19 patients, treated for at least 3 days with the HCQ-AZ combination and a follow-up

of at least 9 days was investigated. Endpoints were death, worsening and viral shedding

persistence.

Findings

From March 3rd to April 9th, 2020, 59,655 specimens from 38,617 patients were tested for

COVID-19 by PCR. Of the 3,165 positive patients placed in the care of our institute, 1061

previously unpublished patients met our inclusion criteria. Their mean age was 43.6 years old

and 492 were male (46.4{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117}). No cardiac toxicity was observed. A good clinical outcome and

virological cure was obtained in 973 patients within 10 days (91.7{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117}). Prolonged viral carriage

at completion of treatment was observed in 47 patients (4.4{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117}) and was associated to a higher

viral load at diagnosis (p < 10-2) but viral culture was negative at day 10 and all but one were

PCR-cleared at day 15. A poor outcome was observed for 46 patients (4.3{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117}); 10 were

transferred to intensive care units, 5 patients died (0.47{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117}) (74-95 years old) and 31 required

10 days of hospitalization or more. Among this group, 25 patients are now cured and 16 are

still hospitalized (98{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117} of patients cured so far). Poor clinical outcome was significantly

associated to older age (OR 1.11), initial higher severity (OR 10.05) and low

Interpretation

The HCQ-AZ combination, when started immediately after diagnosis, is a safe and efficient

treatment for COVID-19, with a mortality rate of 0.5{154653b9ea5f83bbbf00f55de12e21cba2da5b4b158a426ee0e27ae0c1b44117}, in elderly patients. It avoids

worsening and clears virus persistence and contagiosity in most cases.

[1] https://www.mediterranee-infection.com/wp-content/uploads/2020/04/Abstract_Raoult_EarlyTrtCovid19_09042020_vD1v.pdf

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.

Please DONATE TODAY To Help Our Non-Profit Mission To Defend The Scientific Method.

Share this: Twitter

Facebook

LinkedIn

Reddit

Print

Email

More

Telegram

Pinterest



WhatsApp

Pocket



Skype

Tumblr





Related